Antoinette Hollestelle

18PUBLICATIONS
212CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMultiphysics flows (incl. multiphase and reacting flows)Cancer geneticsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Feb 24, 2024
Functional Homologous Recombination (HR) Screening Shows the Majority of BRCA1/2-Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient.

Titia G Meijer, John W M Martens, Wendy J C Prager-van der Smissen

|Jan 11, 2024
Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a BRCA1/2 Mutation.

Shuoying Qu, A Mieke Timmermans, Bernadette A M Heemskerk-Gerritsen

|Jul 14, 2023
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.

Gisella Figlioli, Amandine Billaud, Qin Wang

|Jan 27, 2023
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.

Gisella Figlioli, Amandine Billaud, Thomas U Ahearn

|Sep 22, 2022
Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study.

Bernadette A M Heemskerk-Gerritsen, Antoinette Hollestelle, Christi J van Asperen

|Jul 27, 2022
Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry.

Martine Dumont, Nana Weber-Lassalle, Charles Joly-Beauparlant

Pageof 3

Frequent Collaborators

10 joint publications

Irene L Andrulis

10 joint publications

Paul D P Pharoah

9 joint publications

Peter Devilee

9 joint publications

Joe Dennis